Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
29 March 2019 | Story Lacea Loader

No deregistration of students at the University of the Free State (UFS) will be effected until after the Financial Appeals Committee has concluded its process on 5 April 2019.

During a meeting between the university management and the Institutional Student Representative Council (ISRC) today, the following agreement was reached:

  1. The date for the submission of appeals has been extended to Tuesday 2 April 2019 at 12:00. No further extension will be given. The application form for the Financial Appeals Committee has previously been sent to the ufs4life email addresses of all provisionally registered students.
  2. Students who have appealed their National Student Financial Aid Scheme (NSFAS) outcomes will not be deregistered while awaiting the result of the outcome of their appeal.
  3. Verified final-year students who are provisionally registered will not be deregistered. This will be subject to verification by the Financial Appeals Committee. These students must also submit an appeal.
  4. All other categories of students must submit their appeals to the Financial Appeals Committee.

NB: The documentation mentioned above must be submitted to the Student Finance Office as indicated on the financial appeals form sent to students via their ufs4life email address.

The UFS has taken a pro-poor approach to assist students who are academically deserving. With this approach, the university’s fee structure is much less than that of many public institutions of higher learning in the country. Senior students are also supported through a provisional registration process that grants them the opportunity to pay a reduced amount in order to register, enabling them to fully participate in all activities while extension is provided to secure the necessary funding for their studies.

The university has made a number of concessions to ensure that students are not financially excluded during the 2019 academic year. Many of these concessions were raised by the ISRC on behalf of students and was agreed upon by the university management.  

These concessions include:

  1. Students who have confirmed NSFAS funding for 2019 with historic debt, are to secure registration. This has taken place before the announcement on 24 March 2019 by the Minister of Higher Education and Training, Naledi Pandor, that the historic debt of NSFAS students will be settled by the department.

     

  2. Students in the missing middle who received a gap grant in 2018, have been assisted to pay a lesser amount to register fully for 2019.

     

  3. Students with historic debt who are not receiving the gap grant have also been assisted to register for 2019. Acceptable payment plans for these students have been agreed upon with the university’s Student Finance Office.

     

  4. First-time entering students were assisted with a reduced first payment to enable them to register for 2019.

     

  5. Final-year students with historic debt of less than R20 000 who could not have been assisted in any of the above concessions explained above were allowed to register.

     

  6. Students who are provisionally registered and who could not find the necessary financial means, had the opportunity to submit appeals to the Financial Appeals Committee by 29 March 2019 to secure their registration. This committee comprises representatives of the university management, as well as members of the ISRC. This committee is scheduled to meet on 5 April 2019.

The above is evidence of the multi-layered efforts by the university to support academic deserving students as far as it is practically possible in order to avoid financial exclusion. Additionally, the university’s Student Finance Office has since the beginning of the academic year communicated extensively on the process with students who are at risk of being deregistered.  

Historically, less than 0,5% of registered students at the UFS are not able to find the necessary means to secure their registration.

To support students in their academic efforts, all matters pertaining to registration should be concluded by the end of the first term. A cut-off date is set by which all registration processes – including concessions – are to be concluded. This date – 31 March 2019 – has already been set in 2018, which is the result of consultation with all relevant stakeholders, including the IRSC.

This cut-off date has now been extended to Tuesday 2 April 2019 at 12:00.

Released by:

Lacea Loader (Director: Communication and Marketing)
Telephone: +27 51 401 2584 | +27 83 645 2454
Email: news@ufs.ac.za | loaderl@ufs.ac.za
Fax: +27 51 444 6393



News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept